BONE BIOLOGICS CORP (BBLG) Stock Cash Flow
NASDAQ:BBLG - Nasdaq - US0980705018 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 3.82M | -4.11M | -8.95M | -1.48M | -1.61M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -241.50K | -150.30K | 132.90K | -170.00K | -320.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 10.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 927.10K | 137.70K | -740.10K | -1.91M | 700.00K | |||
| OPERATING CASH FLOW | 4.50M | -4.12M | -9.56M | -3.57M | -1.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.05M | |||
| Stock Issued/Repurchased | -273.10K | 4.42M | 5.04M | 4.43M | 6.86M | |||
| FINANCING CASH FLOW | -273.10K | 4.42M | 5.04M | 4.43M | 7.90M | |||
| CHANGE IN CASH | 4.23M | 298.60K | -4.51M | 860.00K | 6.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 4.50M | -4.12M | -9.56M | -3.57M | -1.23M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | 4.50M | -4.12M | -9.56M | -3.57M | -1.23M | |||
All data in USD